Skip to content
Menu

Reunion Neuroscience Inc. REUN.TO

Full chart Compare
Set alert

Price alert · REUN.TO

All alert types
1.42 +1.42

Quote time unavailable

Day range unavailable

52-week range unavailable

Market cap
16.99M
Shares out
11.72M
Forward P/E
-0.90
Beta
4.21

 

No chart data for this range yet.

Key statistics

Enterprise value
-9.98M
PEG ratio
0.00
Price / sales
0.00
Price / book
0.80
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-7.05M
Total cash
27.20M
Total debt
0
Return on equity
-86.35%
Short % of float
0.00%
50-day average
1.25
200-day average
1.55

About Reunion Neuroscience Inc.

Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on REUN.TO — it syncs with the Stock Master app.

Insider holders

REUN.TO insider holders
InsiderRelationLatest transactionDateShares held
Fishman (Barry)Director of IssuerStock split or consolidationAug 10, 202230,000
Fleiman (Hannan)Director of IssuerStock split or consolidationAug 10, 20220
Hewitt (Paula Amy)Senior Officer of IssuerStock split or consolidationAug 10, 2022769
Jafferi (Mujeeb)Director of IssuerStock split or consolidationAug 10, 2022724,516
Levy (Ronan)Director of IssuerStock split or consolidationAug 10, 20220
Lubman (Ellen)Director of IssuerStock split or consolidationAug 10, 202240

Institution ownership

REUN.TO institution ownership
Holder% heldSharesValueReported
Oasis Management Co Ltd.3.99%467,435677.78KMar 30, 2023
AdvisorShares Investments, LLC2.92%342,529496.67KMar 30, 2023
Avidity Partners Management, LP1.29%151,098219.09KMar 30, 2023
One + One Wealth Management, LLC0.65%76,000110.20KMar 30, 2023
Vivaldi Capital Management Lp0.26%30,00043.50KMar 30, 2023
Jane Street Group, LLC0.19%22,75733.00KMar 30, 2023

Fund ownership

REUN.TO fund ownership
Holder% heldSharesValueReported
AdvisorShares Trust-AdvisorShares Psychedelics ETF2.92%342,529496.67KMar 30, 2023
Fidelity NASDAQ Composite Index Fund0.01%9251.34KFeb 27, 2023